An interventional study of The "dao qi tong luo" group and The acupuncture group in Tinnitus, sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University. Recruiting at 1 site in China. Open to participants aged 20 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-03.
Sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Tinnitus with a site in China — 18 open to participants now, 18 under way, none of them phase 3. Tinnitus · China.
Among the 32 studies in Tinnitus with a site in China, this one is the 19th largest by planned enrollment of the 27 interventional ones that give a count, is one of 6 that started in 2024, is one of 27 with no phase, reaches primary completion later than 6 of the 17 other live ones, and was the 18th registered.
446 studies on the registry are indexed under Tinnitus; 98 are open to participants now.
Browse Tinnitus studies →18 of the 32 studies in Tinnitus with a site in China are open now. Recruiting first, the newest first:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Sites in China
Ages 18–80
The First Affiliated Hospital with Nanjing Medical University · Sites in China
Ages 18+
Eye & ENT Hospital of Fudan University · Sites in China
Ages 18–80
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Ages 18–60
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Sites in China
Ages 18–60
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 10 take healthy volunteers.
This study: 20 Years to 55 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 6 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 87 is above the median of 60 across 370 interventional studies indexed under Tinnitus.
Median enrollment 120 across the 27 interventional studies, 150 across the 5 observational. Of the 9 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 32 has an industry lead sponsor. The 10 most frequent:
The Third Affiliated hospital of Zhejiang Chinese Medical University is the lead sponsor of 45 studies on the registry; 25 are open to participants now.
The Third Affiliated hospital of Zhejiang Chinese Medical University has 4 studies filed under Tinnitus — fewer than ten, so there is no comparison to draw.
5 of the studies in Tinnitus with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07700069Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityAcupuncture Versus Sham Acupuncture for Tinnitus | 2026-12-31 |
| NCT07558837Eye & ENT Hospital of Fudan UniversityFudan Tinnitus Doctor for Tinnitus Management | 2027-05-30 |
| NCT05453019Chinese PLA General HospitalEffects of CI on Tinnitus and Its Symptoms | 2027-07-01 |
| NCT07185061The First Affiliated Hospital with Nanjing Medical UniversityInterventional Treatment of Chronic Tinnitus With Acoustic Stimulation | 2027-07-01 |
| NCT07515482Dan BingManual Acupuncture for Acute Primary Tinnitus | 2027-10-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 32 studies in Tinnitus with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
By comparing the clinical manifestations, ABR parameters and cerebral cortex blood oxygen levels of chronic tinnitus patients and healthy subjects under two different body states, the peripheral-central correlation of chronic tinnitus patients was explored, and the modern scientific significance of the theory of "two ears connecting the brain" was initially expounded. On this basis, the immediate and cumulative effects and peripheral-central correlation of "dao qi tong luo" intervention in chronic tinnitus were observed, and the effective mechanism of "dao qi tong luo" treatment was explored.
The study will enroll 15 healthy subjects and 72 subjects with chronic tinnitus. Functional near infrared spectroscopy (fNIRS) will be used to examine specific brain regions, and ABR techniques will record auditory brainstem responses in chronic tinnitus patients and healthy subjects. Lateral comparison was made between chronic tinnitus patients and healthy subjects on the parameters of auditory brainstem response and the level of oxygen outside the cerebral cortex, and the data of the two were integrated to conduct correlation analysis and correlation analysis with clinical manifestations, so as to compare the correlation between peripheral and central auditory function in different body states. Subsequently, the chronic tinnitus subjects will undergo a course of acupuncture treatment. At the end of acupuncture and moxibustion treatment, the immediate and cumulative effects and peripheral - central correlation of "dao qi tong luo" intervention in chronic tinnitus were observed, and the effective mechanism of "dao qi tong luo" treatment was explored.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Inclusion criteria for patients with chronic tinnitus
<!-- -->
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects in the "dao qi tong luo" group will undergo acupuncture treatment, which is administered 10 times
Procedure: The "dao qi tong luo" group
Subjects in the acupuncture group will undergo acupuncture treatment, which is administered 10 times
Procedure: The acupuncture group
The "dao qi tong luo" group will accept acpuncture. Acupuncture will be performed at acupoints including TE17 (Yifeng), SI19 (Tinggong), GB2 (Tinghui), TE5 (Waiguan), TE3 (Zhongzhu) and etc. Among them, the "dao qi tong luo" group will make patients feel qi.
The acupuncture group will accept acpuncture. Acupuncture will be performed at acupoints including TE17 (Yifeng), SI19 (Tinggong), GB2 (Tinghui), TE5 (Waiguan), TE3 (Zhongzhu) and etc. The acupuncture group will not feel qi.
Tinnitus Handicap Inventory (THI)
Tinnitus Handicap Inventory is based on relevant expert consensus. THI scores range from 0 to 100, with the higher the score, the more severe the condition
Time frame: at baseline (pre-treatment),procedure
Tinnitus Evaluation Questionnaire (TEQ)
Tinnitus Evaluation Questionnaire is based on relevant expert consensus. TEQ scores range from 0 to 21, with the higher the score, the more severe the condition
Time frame: at baseline (pre-treatment), procedure
Auditory Brainstem Response (ABR)
Auditory Brainstem Response is based on relevant expert consensus
Time frame: at baseline (pre-treatment), procedure
Functional Near-Infrared Spectroscopy (Fnirs)
Functional Near-Infrared Spectroscopy is based on relevant expert consensus
Time frame: at baseline (pre-treatment), procedure
Plan to share: No
No publications or documents are linked to this record.
Started May 2024 (actual). Primary completion is estimated for Aug 2026, 27 months after the start.
Of 134 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 27 months is above that.
Counting every sponsor, half of 153 studies reached it within 17 months; a quarter within 10 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Third Affiliated hospital of Zhejiang Chinese Medical University